key: cord-0721441-u631ocxg
authors: Nasiri, Soheila; Dadkhahfar, Sahar; Abasifar, Hajar; Mortazavi, Nafiseh; Gheisari, Mehdi
title: Urticarial vasculitis in a COVID‐19 recovered patient
date: 2020-08-09
journal: Int J Dermatol
DOI: 10.1111/ijd.15112
sha: a8f7385b48177f6355102256f9f6b9b03a9d218f
doc_id: 721441
cord_uid: u631ocxg

nan

COVID-19, but its involvement may be underreported. 2 Herein, we report a case of COVID-19 who developed urticarial vasculitis after recovery.

On March 24, 2020, a 64-year-old woman presented to the emergency room with fever, dry cough, dyspnea, nausea, and anorexia. The past medical history was significant for diabetes mellitus and hypertension. She was screened for COVID-19 with a low-dose chest CT scan that showed patchy parenchymal ground-glass opacities with peripheral distribution typical for COVID-19 infection. Her lab tests showed a normal WBC count without lymphopenia and elevated levels of both lactate dehydrogenase (LDH: 554 U/L) and C-reactive protein (CRP: 61 mg/l; Positive > 10). Nasopharyngeal swab reverse transcription polymerase chain reaction (RT-PCR) was positive for SARS-CoV-2.

She was treated with hydroxychloroquine (200 mg BD) and azithromycin 250 mg/day for 5 days with advice to keep home quarantine, which led to a gradual improvement of the symptoms.

On April 22, 2020, she presented again with weakness, malaise, anorexia recurring for the previous 1 week, and newonset generalized skin lesions. Skin lesions had appeared abruptly 48 hours before the presentation. Therefore, dermatologists need to be vigilant and consider COVID-19 in any susceptible patient during the current pandemic.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Cutaneous manifestations in COVID-19: lessons learned from current evidence

Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome

Vascular skin symptoms in COVID-19: a french observational study

Urticarial eruption in COVID-19 infection

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

The complement system and C1q in chronic hepatitis C virus infection and mixed cryoglobulinemia